The FDA has approved mixing and matching coronavirus concoctions between different manufacturers. The FDA booster study showed participants initially injected with Johnson & Johnson, primary dose could gain a higher level of immunity using an mRNA vaccine as a second injection.
The news of using heterologous boosters of various manufacturers challenges the efficacy of those who chose to receive the Johnson & Johnson vaccine. Could this be the end of the Janssen viral vector vaccine, as it begins progressively “phasing out” of the suggested required vaccines?
Vaccine boosters may be the future means of ensured profit for Big Pharma, however as new vaccine booster data emerges (as seen in Israel), the statement that these concoctions are required becomes evidently more ludicrous.
Booster Efficacy
Emerging evidence also shows that among healthcare and other frontline workers, vaccine effectiveness against COVID-19 infections is also decreasing over time. The lower effectiveness is likely due to the combination of decreasing protection as time passes since getting vaccinated as well as the greater infectiousness of the Delta variant.
What is the immunity difference in efficacy among mixing and matching coronavirus injections?
- Patients who received a second dose of Johnson & Johnson (Janssen) raised a 4-fold increase in antibody levels
- Patients who received the Pfizer-BioNTech (Comirnaty) booster shot increased antibody levels in Johnson & Johnson recipients 35-fold
- Patients who received Moderna boosters had an 76-fold antibody surge (within 15 days)
Booster Eligibility
Who is eligible to receive a booster shot?
Johnson & Johnson: You are eligible for a booster if you are 18 years or older, and have received the initial dose at least 2 months after receiving the Johnson & Johnson/Janssen COVID-19 vaccine.
In case you didn’t catch it, the CDC’s official website reads “at least 2 months after your second dose”. This is horrifyingly incorrect. Read the full error report here
Johnson & Johnson Boosters –
Read the full Johnson & Johnson (Janssen) Booster report
Pfizer-BioNTech // Moderna:
You are eligible every for a Pfizer-BioNTech or Moderna booster if you are 18+ (under special conditioning), with eligibility extended to all Americans 65 years and older.
“The door just keeps getting wider and wider,” said Dr. Paul Offit.
For more details, information, and hidden corruption on Pfizer-BioNTech’s (Comirnaty) and Moderna’s booster shot vaccinations visit both official booster reports below:
Pfizer-BioNTech (Comirnaty) Boosters –
Read the full Pfizer-BioNTech booster report
Moderna Boosters –
Read the full Moderna booster report
Booster Dosages
The booster dose and volume are the same regardless of whether the dose is homologous or heterologous.
- Pfizer-BioNTech: 30 ug in a volume of 0.3 ml (same as the primary series and additional doses)
- Moderna: 50 µg in a volume of 0.25 ml. This is half the amount used for the primary series and additional dose.
- Janssen: 5×1010 viral particles in a volume of 0.5ml (same as the primary series doses).
Statements
Dr. Kirsten E. Lyke –
“Part of the beauty of the mix and match is it enables people no matter where they are — rural or in the city — to have a choice,” said Dr. Kirsten E. Lyke, a professor at the University of Maryland School of Medicine who presented early results of a booster shot trial to the F.D.A. vaccine panel. “They’re all safe, they’re all going to give you a boost, and they’re all going to protect you against severe disease and death.”
Scott Hensley –
“At the end of the day, folks having the Johnson & Johnson should probably get an mRNA booster,” said Scott Hensley, an immunologist at the University of Pennsylvania. “It’s just a matter of, how much data does the F.D.A. need before making that recommendation?”
“I wouldn’t want to be in their shoes,” Hensley added.
Dr. Celine Grounder –
“There are some of us who would really like to see more data,” said Dr. Celine Gounder, an infectious disease specialist at Bellevue Hospital Center in New York. “And then there are others who want to just move forward on boosters.”
Conclusion
Although the duration of coronavirus protection after vaccination is still largely unknown, and subject to debate, health advisors have already begun rolling out third doses for those who qualify.
Was this booster vaccine rollout rushed against the known data for pharmaceutical profit? Who paid for these potions, and where do those tax dollars go? Americans elected officials have become extensions of iatrarchy, reducing our nation to a state of kakistrocracy.
With medical privacy now a distant memory, mass surveillance and “resistance re-education” has begun their infiltration into our western society. Should basic human rights be a form of currency? Should the quality of human beings be judged on their vaccination status? Has the coronavirus pandemic mutated to become more about control, financial profit, and power, than about saving the lives of the people it was created to protect?
JMBK.NEWS 